These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 5797171)

  • 21. An approach to the treatment of progressive muscular dystrophy.
    PERSSON I
    Int Rec Med Gen Pract Clin; 1957 Mar; 170(3):131-6. PubMed ID: 13405605
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies on progressive muscular dystrophy. I. Effects of adenosinetriphosphate and its related compounds on progressive muscular dystrophy.
    Nakahara M
    Arzneimittelforschung; 1965 Jun; 15(6):591-5. PubMed ID: 4223122
    [No Abstract]   [Full Text] [Related]  

  • 23. [Vitasic magnetophoresis in the treatment of primary reticular corneal dystrophy].
    Larina LA; Maĭchuk IuF
    Vestn Oftalmol; 1998; 114(6):23-5. PubMed ID: 9951380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LAEVADOSIN IN MUSCULAR DYSTROPHY.
    WALTON JN; GUBBAY SS; HUDGSON P; NEWELL DJ
    Br Med J; 1965 Aug; 2(5460):533. PubMed ID: 14321233
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies on progressive muscular dystrophy. II. Relation between clinical effect of adenosinetriphosphate on progressive muscular dystrophy and phosphate compounds in the muscle.
    Nakahara M
    Arzneimittelforschung; 1965 Jul; 15(7):782-5. PubMed ID: 5898681
    [No Abstract]   [Full Text] [Related]  

  • 26. LAEVADOSIN IN MUSCULAR DYSTROPHY.
    THOMSON WH
    Br Med J; 1965 Sep; 2(5462):647. PubMed ID: 14331636
    [No Abstract]   [Full Text] [Related]  

  • 27. [On a practical possibliity of trophic and kinetic therapy of chronic cardiac decompensation].
    Bosisio P; Cima G
    Minerva Med; 1965 Sep; 56(76):3229-36. PubMed ID: 5837025
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of myopathies with ribonucleotides].
    Grinio LP; Korabel'nikova NI; Shabanova ME; Medvedev MI; Islamova IB; Bobrova KF
    Sov Med; 1991; (8):91. PubMed ID: 1763382
    [No Abstract]   [Full Text] [Related]  

  • 29. Strategies for reducing intestinal atrophy during total parenteral nutrition: role of intravenous nucleosides and nucleotides.
    Shenkin A
    Nutrition; 1994; 10(2):203-4. PubMed ID: 8025383
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of progressive muscular dystrophy with anabolics and uridine-5-triphosphoric acid].
    Valente VL; Caprarulo CC; Luchetta MR; Nenkies L; Miani J; De Zubizarreta CS
    Prensa Med Argent; 1966 May; 53(20):1130-4. PubMed ID: 5916532
    [No Abstract]   [Full Text] [Related]  

  • 31. TREATMENT OF MUSCULAR DYSTROPHY WITH A NUCLEOTIDES- NUCLEOSIDES COMBINATION.
    GUEST KE; MCLAY WD
    Br J Clin Pract; 1964 Jul; 18():395-400. PubMed ID: 14196785
    [No Abstract]   [Full Text] [Related]  

  • 32. [Long term results of intraarterial infusion therapy in peripheral arterial occlusive diseases].
    Hild R; Spaan G; Stein U
    Med Welt; 1981 Apr; 32(14):448-51. PubMed ID: 7219157
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment problems using anabolic steroids in progressive muscular dystrophy].
    Badalian LO; Temin PA; Mukhin KIu
    Klin Med (Mosk); 1984 Nov; 62(11):23-9. PubMed ID: 6394898
    [No Abstract]   [Full Text] [Related]  

  • 34. Nucleosides and nucleotides as potential therapeutic agents.
    Shen TY
    Angew Chem Int Ed Engl; 1970 Sep; 9(9):678-88. PubMed ID: 4990680
    [No Abstract]   [Full Text] [Related]  

  • 35. Allopurinol not effective in muscular dystrophy.
    Bakouche P; Chaouat D; Nick J
    N Engl J Med; 1979 Oct; 301(14):785. PubMed ID: 481489
    [No Abstract]   [Full Text] [Related]  

  • 36. [The effect of vitamin PP on the indices of electro-excitability of the neuro-muscular system in neurologic patients].
    Sliusarev FM; Buchinskiĭ AG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(6):854-7. PubMed ID: 4233554
    [No Abstract]   [Full Text] [Related]  

  • 37. [Long term observations in muscular dystrophy. Therapeutic influence of disease course in progressive muscular dystrophy (8 long term observations)].
    Schlenska GK; Kleine TO
    Med Welt; 1980 Jun; 31(25):940-4. PubMed ID: 6775171
    [No Abstract]   [Full Text] [Related]  

  • 38. [Duchenne muscular dystrophy. Effects of vitamin E administration on urinary luminescence].
    Pizarro M; Lissi E; Reyes J; Holmgren J
    Rev Med Chil; 1998 Oct; 126(10):1165-72. PubMed ID: 10030087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suggestion for a possible mitigating treatment of Duchenne muscular dystrophy.
    Zatz M; Frota-Pessoa O
    Am J Med Genet; 1981; 10(3):305-7. PubMed ID: 7304675
    [No Abstract]   [Full Text] [Related]  

  • 40. [Association of coronarodilatory & cardiotrophic drugs in the treatment of coronary insufficiency].
    FAUDA C; GRIGOLATO V; CANDIANI C
    Minerva Med; 1959 Mar; 50(22):791-7. PubMed ID: 13656696
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.